1. Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016;67:e27-e115.
2. Salerno JC, Kertesz NJ, Friedman RA, et al. Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children <3 or >3 or = 3 years of age. J Am Coll Cardiol. 2004;43:438-444.
3. Doniger SJ, Sharieff GQ. Pediatric dysrhythmias. Pediatr Clin North Am. 2006;53:85-105.
4. Ferguson JD, DiMarco JP. Contemporary management of paroxysmal supraventricular tachycardia. Circulation. 2003;107:1096-1099.
5. Poutiainen AM, Koistinen MJ, Airaksinen KE, et al. Prevalence and natural course of ectopic atrial tachycardia. Eur Heart J. 1999;20:694-700.
6. Loomba RS, Chandrasekar S, Sanan P, et al. Association of atrial tachyarrhythmias with atrial septal defect, Ebstein's anomaly and Fontan patients. Expert Rev Cardiovasc Ther. 2011;9:887-893.
7. DeVoe JE, Judkins DZ, Woods L. What is the best approach to the evaluation of resting tachycardia in an adult? J Fam Pract. 2007;56:59-61.
8. Thavendiranathan P, Bagai A, Khoo C, et al. Does this patient with palpitations have a cardiac arrhythmia? JAMA. 2009;302:2135-2143.
9. Hanrahan JP, Grogan DR, Baumgartner RA, et al. Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. Medicine (Baltimore). 2008;87:319-328.
10. Gerstenfeld EP, Marchlinski FE. Mapping and ablation of left atrial tachycardias occurring after atrial fibrillation ablation. Heart Rhythm. 2007;4(3 suppl):S65-S72.
11. Chauhan VS, Krahn GJ, Skanes AC, et al. Supraventricular tachycardia. Med Clin North Am. 2001;85:193-223.
12. Fox DJ, Tischenko A, Krahn AD, et al. Supraventricular tachycardia: diagnosis and management. Mayo Clin Proc. 2008;83:1400-1411.
13. Innes JA. Review article: adenosine use in the emergency department. Emerg Med Australas. 2008;20:209-215.
14. Engelstein ED, Lippman N, Stein KM, et al. Mechanism-specific effects of adenosine on atrial tachycardia. Circulation. 1994;89:2645-2654.
15. Vecht JA, Saso S, Rao C, et al. Atrial septal defect closure is associated with a reduced prevalence of atrial tachyarrhythmia in the short to medium term: a systematic review and meta-analysis. Heart. 2010;96:1789-1797.
16. Pichon-Riviere A, Augustovski F, Garcia Marti S, et al. Cryoablation in cardiac arrhythmias in pediatric patients. Ciudad de Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS); 2008.
17. Antman EM, Wenger TL, Butler VP Jr, et al. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: final report of a multicenter study. Circulation. 1990;81:1744-1752.
18. Perry J, Fenrich AL, Hulse JE, et al. Pediatric use of amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol. 1996;27:1246-1250.
19. Nerheim P, Birger-Botkin S, Piracha L, et al. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation. 2004;110:247-252.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台